David I. Israel

5.6k citations
31 papers · 3.7k indexed · 2 hit papers · h-index 21

David I. Israel

30 papers receiving 3.5k citations

Hit Papers

Bone Morphogenetic Protein-2 Causes Commitment and Differ...42719902026200220144008001.2k

Peers

David I. Israel
Comparison fields: 5 of 108
  • Urology 380
  • Oral Surgery 316
  • Rheumatology 485
  • Molecular Biology 1.8k
  • Cancer Research 390
Replace Kimimitsu Oda with:
Kimimitsu Oda Japan
Saeid M. Seyedin United States
Sevgi B. Rodan United States
Xiaojuan Sun China
Philip Osdoby United States
Gilbert Vaes Belgium
Giuseppe Pirozzi Italy
Béatrice Dozin Italy
Takuhiko Akatsu Japan
Gero Brockhoff Germany
David I. Israel relative to Kimimitsu Oda Japan Kimimitsu Oda's profile →
Citations per field
00.5×3.0×
Kimimitsu Oda · 1×
Citations per year

Countries citing papers authored by David I. Israel

Since Specialization
Citations

This map shows the geographic impact of David I. Israel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Israel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Israel more than expected).

Fields of papers citing papers by David I. Israel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David I. Israel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Israel. The network helps show where David I. Israel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David I. Israel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David I. Israel Line = papers co-authored together David I. Israel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20221
3 20221
4 202126
5 202010
6 202013
7 20069
8 20061
9 20061
10 200259
11 1996277
12 1993145
13 1993112
14
Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 Cellsbreakdown →
1993427
15 199327
16 1992158
17 199020
18 198959
19 1989147
20 1983103

About David I. Israel

David I. Israel is a scholar working on Pharmacology, Hematology and Virology, having authored 31 papers that have together received 3.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Chemical Synthesis and Analysis (4 papers), Bone Tissue Engineering Materials (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Toxic Organic Pollutants Impact (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Hemophilia Treatment and Research (3 papers). The work is most often cited by research in Urology (380 citations), Oral Surgery (316 citations) and Rheumatology (485 citations). David I. Israel has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include James P. Whitlock, Kelvin M. Kerns, Randal J. Kaufman, Vicki Rosen, Rodney M. Hewick, Josephine D’Alessandro, Tomoaki Harada, Peter LaPan, Deborah Luxenberg and Shannon Kelly.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026